Atlas Trials

Acute Effects of SGLT2 Inhibition on Renal Oxygenation and Autonomic Function in Type 1 Diabetes

Clinical trial NCT04193566 · COMPLETED

Trial details

NCT number
NCT04193566
Sponsor
Steno Diabetes Center Copenhagen
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
NephropathyHypoxiaMitochondrial AlterationType 1 DiabetesAutonomic Neuropathy, Diabetic
Start date
2020-02-01
Primary completion
2020-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.